Portuguese surveillance catches Chinese laser device without CE mark
This article was originally published in Clinica
Executive Summary
Portuguese regulatory authorities have raised the alarm over the presence of a falsely CE-marked Chinese laser therapy device on the European market. In an alert issued on 30 December, the Infarmed agency warns that the Fractional Laser Treatment System MED-850, manufactured by Beijing KES Biology Technology Co, must not be used. The alert notes that the Institute for Testing and Certification, the Czech notified body declared as having performed the conformity assessment of the device, had confirmed that the CE mark was not valid and that it had not assessed the device. The product was being supplied in Portugal by Spanish distributor Nutridermo Vital, based in Valencia.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.